Concepedia

Author

B Desablens

Centre Hospitalier Universitaire Amiens-Picardie

Also Known As

B Desablens, B. Desablens, Bernard Desablens, C Granthil, Desablens, Bernard, N Simon, R Faroux

167

Publications

4.9K

Citations

30

H-Index

65

Concepts

All Affiliations

Centre Hospitalier Universitaire Amiens-PicardieCentre Hospitalier Universitaire de ToursHôpital NordCentre Hospitalier Universitaire d'AngersHôpital Laennec
BD

About

B Desablens is an author at Centre Hospitalier Universitaire Amiens-Picardie specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

27

1.5K

2

Health Sciences

11

12

675

3

Blood Transplantation

2

2

79

4

Engineering

1

1

18

5

Cell Biology

1

1

43

B Desablens

×

60

Publications

4.7K

Citations

30

H-Index

YearCitations

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret,

Blood

1999

743

Chlorambucil in Indolent Chronic Lymphocytic Leukemia

Guillaume Dighiero, Karim Maloum, B Desablens,

New England Journal of Medicine

1998

442

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

M Leporrier, Sylvie Chevret, Bruno Cazin,

Blood

2001

393

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Jean‐Luc Harousseau, Jean‐Yves Cahn, B. Pignon,

PubMed

1997

317

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.

Hervé Tilly, Sylvie Castaigné, Dominique Bordessoule,

Journal of Clinical Oncology

1990

258

Primary Central Nervous System Lymphomas in 72 Immunocompetent Patients: Pathologic Findings and Clinical Correlations

Sophie Camilleri‐Broët, Antoine Martin, R Angonin,

American Journal of Clinical Pathology

1998

172

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

P Colombat, A. Lemevel, P Bertrand,

Bone Marrow Transplantation

2006

166

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

Audrey Simon, Michel Péoc’h, Philippe Casassus,

British Journal of Haematology

2010

165

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Emmanuel Gyan, Charles Foussard, Philippe B. Bertrand,

Blood

2008

153

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Francis Witz, Alain Sadoun, M. C. Perrin,

PubMed

1998

147

Page 1